AACR 2024: What Cancer Researchers Are Talking About 4/10/2024
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC 7/9/2024
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study 7/9/2024
House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year 7/9/2024
Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D 7/9/2024
FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication 7/9/2024
US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead 7/9/2024
What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges? 7/9/2024
Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall 7/9/2024
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data 7/9/2024
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024
Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024 5/9/2024
Women's Health: Where Politics and Science Meet 5/9/2024
Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies 5/9/2024
Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds 5/9/2024
Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases 5/9/2024
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop 5/9/2024
DEIB Evolves As Criticism, Changing Attitudes Continue 5/9/2024
Dry Promotions: Dealing With a Double-Edged Sword 5/9/2024
Top 5 Companies Hiring in the Boston Area 5/9/2024